COMMENTWIRE: Breo approved in COPD, but others are breathing down its neck
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline can push ahead with a new franchise in COPD (and possibly asthma) but it really only has months to go before the competition starts to get out there on the market.